Cancer Gene Therapy - Table of Contents alert Volume 20 Issue 2

TABLE OF CONTENTS Volume 20, Issue 2 (February 2013) In this issue Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement New Year! New journal for your research! Celebrate with 50% off the article processing charge Submit your research to Blood Cancer Journal between January and March 2013 and receive 50% off the article processing charge. This offer is for a limited time only. Indexed by PubMed and Thomson Reuters. Submit your research today and quote discount code BCJ50APC13 (Offer expires 31st March 2013)   Reviews Top TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases A Deisseroth, Y Tang, L Zhang, H Akbulut and N Habib Cancer Gene Ther 2013 20: 65-69; advance online publication, December 14, 2012; 10.1038/cgt.2012.87 Abstract | Full Text Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers I-K Choi and C-O Yun Cancer Gene Ther 2013 20: 70-76; advance online publication, January 11, 2013; 10.1038/cgt.2012.95 Abstract | Full Text Original Articles Top Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer X Yin, B Yu, Z Tang, B He, J Ren, X Xiao and W Tang Cancer Gene Ther 2013 20: 77-81; advance online publication, December 21, 2012; 10.1038/cgt.2012.86 Abstract | Full Text c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5 S Y Kim, J-H Kim and J J Song Cancer Gene Ther 2013 20: 82-87; advance online publication, January 11, 2013; 10.1038/cgt.2012.88 Abstract | Full Text The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells M C White and A R Frampton, Jr Cancer Gene Ther 2013 20: 88-93; advance online publication, January 11, 2013; 10.1038/cgt.2012.89 Abstract | Full Text Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA S Oh, E Kim, D Kang, M Kim, J-H Kim and J J Song Cancer Gene Ther 2013 20: 94-100; advance online publication, January 11, 2013; 10.1038/cgt.2012.90 Abstract | Full Text RNA interference targeting human FAK and EGFR suppresses human non-small-cell lung cancer xenograft growth in nude mice C Li, X Zhang, L Cheng, L Dai, F Xu, J Zhang, H Tian, X Chen, G Shi, Y Li, T Du, S Zhang, Y Wei and H Deng Cancer Gene Ther 2013 20: 101-108; advance online publication, January 18, 2013; 10.1038/cgt.2012.91 Abstract | Full Text Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins A W Hudacek, C K Navaratnarajah and R Cattaneo Cancer Gene Ther 2013 20: 109-116; advance online publication, January 11, 2013; 10.1038/cgt.2012.92 Abstract | Full Text Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer C Yang, H Chen, L Yu, L Shan, L Xie, J Hu, T Chen and Y Tan Cancer Gene Ther 2013 20: 117-124; advance online publication, January 11, 2013; 10.1038/cgt.2012.94 Abstract | Full Text Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling W Malilas, S S Koh, R Srisuttee, W Boonying, I-R Cho, C-S Jeong, R N Johnston and Y-H Chung Cancer Gene Ther 2013 20: 125-132; advance online publication, January 11, 2013; 10.1038/cgt.2012.96 Abstract | Full Text Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis Y Kulu, H Kawasaki, J M Donahue, H Kasuya, J C Cusack, E W Choi, D K Kuruppu, B C Fuchs and K K Tanabe Cancer Gene Ther 2013 20: 133-140; advance online publication, January 25, 2013; 10.1038/cgt.2012.97 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.